Targeted Oncology · 2016 · 37 citations · 5 references
MedicineImmunologyNephrologyImmunopathologyImmunotherapyRenal PathophysiologyImmune-mediated Renal DiseaseRenal DiseaseRenal ImmunopathologyRenal ToxicityHypervolemic HyponatremiaHyponatremia TreatmentImmune Complex NephritisImmune Complex-mediated NephritisImmune-mediated NephritisImmune-mediated NephrotoxicityInfusion Safety
5
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi, Steven O’Day, David F. McDermott et al. · New England Journal of Medicine · 2010 · 15.2K citations · Full text
A method for estimating the probability of adverse drug reactions
C. A. Naranjo, U. Busto, Edward M. Sellers et al. · Clinical Pharmacology & Therapeutics · 1981 · 11.6K citations
Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation
Caroline Robert, Georgina V. Long, Benjamin Brady et al. · New England Journal of Medicine · 2014 · 5.4K citations · Full text
Medicine, Oncology, Pharmacotherapy +14
Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma
Michael A. Postow, Jason Chesney, Anna C. Pavlick et al. · New England Journal of Medicine · 2015 · 2.8K citations · Full text
Life Sciences, Immunology, Oncology +17
Jeffrey S. Weber, Sandra P. D’Angelo, David R. Minor et al. · The Lancet Oncology · 2015 · 2.7K citations
Medicine, Oncology, Pharmacotherapy +16